ArticleCancer research2012

Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.

Bhuvaneswari Ramaswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.